HK Stock MarketDetailed Quotes

02181 MABPHARM-B

Watchlist
  • 0.315
  • 0.0000.00%
Not Open Dec 13 16:08 CST
1.30BMarket Cap-5.73P/E (TTM)

MABPHARM-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
2.43%-97.57M
0.69%-209.36M
14.39%-100M
27.74%-210.82M
19.53%-116.81M
-58.01%-291.74M
-167.88%-145.16M
8.84%-184.63M
53.16%-54.19M
-32.72%-202.53M
Profit adjustment
Interest (income) - adjustment
-975.00%-215K
60.47%-151K
91.80%-20K
80.45%-382K
76.61%-244K
79.34%-1.95M
87.24%-1.04M
-140.97%-9.46M
-4,270.59%-8.17M
-2,873.48%-3.93M
Impairment and provisions:
18.31%756K
261.86%427K
--639K
1,211.11%118K
----
-60.87%9K
----
-91.54%23K
----
-67.58%272K
-Impairmen of inventory (reversal)
----
----
----
----
----
-60.87%9K
----
-91.54%23K
----
-67.58%272K
-Other impairments and provisions
18.31%756K
261.86%427K
--639K
--118K
----
----
----
----
----
----
Revaluation surplus:
-94.92%-115K
-677.27%-342K
---59K
---44K
----
----
----
----
----
----
-Other fair value changes
-94.92%-115K
-677.27%-342K
---59K
---44K
----
----
----
----
----
----
Asset sale loss (gain):
----
----
----
-145.21%-33K
----
--73K
--73K
----
----
----
-Loss (gain) on sale of property, machinery and equipment
----
----
----
-145.21%-33K
----
--73K
--73K
----
----
----
Depreciation and amortization:
12.58%31.17M
17.74%60.7M
8.39%27.69M
17.49%51.55M
36.94%25.54M
79.85%43.88M
59.67%18.65M
9.75%24.4M
5.91%11.68M
89.74%22.23M
Financial expense
20.45%5.42M
33.25%9.58M
44.91%4.5M
199.13%7.19M
144.99%3.1M
-39.04%2.4M
-51.71%1.27M
-48.77%3.94M
-33.95%2.62M
71.73%7.7M
Exchange Loss (gain)
-83.47%454K
-65.83%1.37M
-4.02%2.75M
-39.31%4M
-38.40%2.86M
-79.34%6.59M
133.97%4.65M
299.86%31.9M
---13.68M
-757.68%-15.96M
Special items
35.66%7.7M
41.15%13.47M
-4.67%5.68M
-22.04%9.54M
-9.35%5.96M
-1.34%12.24M
-4.39%6.57M
-10.39%12.41M
-3.90%6.87M
154.25%13.84M
Operating profit before the change of operating capital
10.93%-52.4M
10.49%-124.31M
26.08%-58.83M
39.22%-138.88M
30.79%-79.59M
-88.19%-228.51M
-109.62%-114.99M
31.93%-121.42M
41.46%-54.86M
-39.55%-178.38M
Change of operating capital
Inventory (increase) decrease
113.69%334K
97.39%-1.24M
91.01%-2.44M
-140.42%-47.59M
-540.71%-27.15M
-76.31%-19.79M
6.36%-4.24M
-322.08%-11.23M
-190.45%-4.53M
-36.25%5.06M
Accounts receivable (increase)decrease
-126.89%-45.48M
-6,992.62%-10.27M
-555.77%-20.05M
101.55%149K
73.34%-3.06M
---9.64M
---11.47M
----
----
----
Accounts payable increase (decrease)
118.64%30.07M
-114.78%-1.8M
-7.31%13.75M
-85.36%12.14M
-76.39%14.84M
2,967.15%82.92M
634.36%62.84M
-108.35%-2.89M
-157.09%-11.76M
-11.69%34.64M
prepayments (increase)decrease
166.04%4.45M
-84.52%2.65M
-178.62%-6.73M
162.98%17.11M
227.46%8.56M
-105.76%-27.17M
64.81%-6.72M
-530.66%-13.21M
-1,215.64%-19.09M
-76.71%-2.09M
Cash  from business operations
15.16%-63.03M
14.07%-134.97M
14.00%-74.3M
22.32%-157.06M
-15.84%-86.39M
-35.93%-202.2M
17.35%-74.58M
-5.66%-148.74M
-29.72%-90.23M
-72.14%-140.78M
Special items of business
-102.81%-1.14M
92.02%192.36M
-45.90%40.76M
3,576.29%100.18M
322.91%75.35M
80.11%2.73M
-756.84%-33.8M
-63.62%1.51M
185.91%5.15M
-79.11%4.16M
Net cash from operations
-91.38%-64.18M
200.89%57.39M
-203.61%-33.53M
71.48%-56.89M
89.81%-11.05M
-35.48%-199.47M
-27.37%-108.38M
-7.77%-147.23M
-12.62%-85.09M
-120.80%-136.62M
Cash flow from investment activities
Interest received - investment
975.00%215K
-60.47%151K
-91.80%20K
-80.45%382K
-76.61%244K
-84.85%1.95M
-82.73%1.04M
2,542.62%12.9M
3,128.88%6.04M
269.70%488K
Loan receivable (increase) decrease
----
----
----
----
----
----
----
----
----
-99.51%42K
Decrease in deposits (increase)
----
----
----
206.11%34.75M
--34.75M
-109.91%-32.75M
----
199.16%330.35M
508.69%287.22M
-63,723.75%-333.16M
Sale of fixed assets
----
----
----
2.38%43K
----
--42K
--42K
----
----
----
Purchase of fixed assets
-77.68%-12.63M
84.78%-19.04M
92.75%-7.11M
15.83%-125.13M
-60.15%-98.06M
24.63%-148.67M
34.07%-61.23M
-73.68%-197.24M
-417.12%-92.87M
-128.11%-113.57M
Recovery of cash from investments
-57.04%30.12M
--15.39M
--70.1M
----
----
----
----
----
----
----
Cash on investment
45.45%-30M
----
---55M
---15M
----
----
----
----
----
----
Other items in the investment business
----
----
----
----
----
----
----
-69.80%10M
----
1,203.63%33.11M
Net cash from investment operations
-253.42%-12.3M
96.66%-3.51M
112.71%8.02M
41.50%-104.96M
-4.86%-63.07M
-215.01%-179.42M
-130.01%-60.15M
137.76%156M
327.68%200.39M
-399.47%-413.09M
Net cash before financing
-199.69%-76.48M
133.30%53.89M
65.57%-25.52M
57.29%-161.84M
56.02%-74.11M
-4,421.26%-378.89M
-246.16%-168.52M
101.60%8.77M
170.49%115.3M
-280.21%-549.71M
Cash flow from financing activities
New borrowing
43.81%31.1M
0.60%123.07M
-72.04%21.62M
--122.33M
--77.33M
----
----
----
----
216.90%95.07M
Refund
-2,122.44%-50.01M
---2.25M
-1.26%-2.25M
----
-480.16%-2.22M
----
99.42%-383K
60.32%-63.09M
43.51%-66.22M
---158.99M
Issuing shares
----
----
----
----
----
----
----
----
----
151.72%1.03B
Interest paid - financing
-36.90%-2.11M
-78.47%-3.4M
-142.07%-1.54M
21.71%-1.9M
50.77%-637K
42.21%-2.43M
54.31%-1.29M
55.13%-4.21M
47.91%-2.83M
-265.47%-9.38M
Issuance expenses and redemption of securities expenses
----
----
----
----
----
----
----
95.79%-1.28M
95.46%-1.28M
-1,342.31%-30.38M
Other items of the financing business
----
-767.06%-26M
----
64.50%-3M
----
-66.12%-8.45M
----
---5.09M
----
----
Net cash from financing operations
-248.44%-22.81M
-23.75%85.6M
-78.95%15.37M
731.36%112.26M
1,727.57%73.01M
77.91%-17.78M
93.91%-4.49M
-108.72%-80.48M
-107.56%-73.66M
259.30%922.76M
Effect of rate
102.90%8K
-81.57%293K
-61.40%-276K
124.01%1.59M
96.33%-171K
79.41%-6.62M
-135.90%-4.66M
-284.05%-32.16M
--12.98M
820.07%17.48M
Net Cash
-878.20%-99.29M
381.34%139.48M
-823.57%-10.15M
87.50%-49.58M
99.36%-1.1M
-453.16%-396.67M
-515.46%-173.01M
-119.22%-71.71M
-94.87%41.64M
232.37%373.05M
Begining period cash
416.40%173.35M
-58.84%33.57M
-58.84%33.57M
-83.18%81.56M
-83.18%81.56M
-17.64%484.85M
-17.64%484.85M
197.04%588.72M
197.04%588.72M
159.27%198.2M
Cash at the end
220.05%74.07M
416.40%173.35M
-71.18%23.14M
-58.84%33.57M
-73.86%80.29M
-83.18%81.56M
-52.25%307.18M
-17.64%484.85M
-36.26%643.35M
197.04%588.72M
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Deloitte Guan Huang Chen Fang Certified Public Accountants
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax 2.43%-97.57M0.69%-209.36M14.39%-100M27.74%-210.82M19.53%-116.81M-58.01%-291.74M-167.88%-145.16M8.84%-184.63M53.16%-54.19M-32.72%-202.53M
Profit adjustment
Interest (income) - adjustment -975.00%-215K60.47%-151K91.80%-20K80.45%-382K76.61%-244K79.34%-1.95M87.24%-1.04M-140.97%-9.46M-4,270.59%-8.17M-2,873.48%-3.93M
Impairment and provisions: 18.31%756K261.86%427K--639K1,211.11%118K-----60.87%9K-----91.54%23K-----67.58%272K
-Impairmen of inventory (reversal) ---------------------60.87%9K-----91.54%23K-----67.58%272K
-Other impairments and provisions 18.31%756K261.86%427K--639K--118K------------------------
Revaluation surplus: -94.92%-115K-677.27%-342K---59K---44K------------------------
-Other fair value changes -94.92%-115K-677.27%-342K---59K---44K------------------------
Asset sale loss (gain): -------------145.21%-33K------73K--73K------------
-Loss (gain) on sale of property, machinery and equipment -------------145.21%-33K------73K--73K------------
Depreciation and amortization: 12.58%31.17M17.74%60.7M8.39%27.69M17.49%51.55M36.94%25.54M79.85%43.88M59.67%18.65M9.75%24.4M5.91%11.68M89.74%22.23M
Financial expense 20.45%5.42M33.25%9.58M44.91%4.5M199.13%7.19M144.99%3.1M-39.04%2.4M-51.71%1.27M-48.77%3.94M-33.95%2.62M71.73%7.7M
Exchange Loss (gain) -83.47%454K-65.83%1.37M-4.02%2.75M-39.31%4M-38.40%2.86M-79.34%6.59M133.97%4.65M299.86%31.9M---13.68M-757.68%-15.96M
Special items 35.66%7.7M41.15%13.47M-4.67%5.68M-22.04%9.54M-9.35%5.96M-1.34%12.24M-4.39%6.57M-10.39%12.41M-3.90%6.87M154.25%13.84M
Operating profit before the change of operating capital 10.93%-52.4M10.49%-124.31M26.08%-58.83M39.22%-138.88M30.79%-79.59M-88.19%-228.51M-109.62%-114.99M31.93%-121.42M41.46%-54.86M-39.55%-178.38M
Change of operating capital
Inventory (increase) decrease 113.69%334K97.39%-1.24M91.01%-2.44M-140.42%-47.59M-540.71%-27.15M-76.31%-19.79M6.36%-4.24M-322.08%-11.23M-190.45%-4.53M-36.25%5.06M
Accounts receivable (increase)decrease -126.89%-45.48M-6,992.62%-10.27M-555.77%-20.05M101.55%149K73.34%-3.06M---9.64M---11.47M------------
Accounts payable increase (decrease) 118.64%30.07M-114.78%-1.8M-7.31%13.75M-85.36%12.14M-76.39%14.84M2,967.15%82.92M634.36%62.84M-108.35%-2.89M-157.09%-11.76M-11.69%34.64M
prepayments (increase)decrease 166.04%4.45M-84.52%2.65M-178.62%-6.73M162.98%17.11M227.46%8.56M-105.76%-27.17M64.81%-6.72M-530.66%-13.21M-1,215.64%-19.09M-76.71%-2.09M
Cash  from business operations 15.16%-63.03M14.07%-134.97M14.00%-74.3M22.32%-157.06M-15.84%-86.39M-35.93%-202.2M17.35%-74.58M-5.66%-148.74M-29.72%-90.23M-72.14%-140.78M
Special items of business -102.81%-1.14M92.02%192.36M-45.90%40.76M3,576.29%100.18M322.91%75.35M80.11%2.73M-756.84%-33.8M-63.62%1.51M185.91%5.15M-79.11%4.16M
Net cash from operations -91.38%-64.18M200.89%57.39M-203.61%-33.53M71.48%-56.89M89.81%-11.05M-35.48%-199.47M-27.37%-108.38M-7.77%-147.23M-12.62%-85.09M-120.80%-136.62M
Cash flow from investment activities
Interest received - investment 975.00%215K-60.47%151K-91.80%20K-80.45%382K-76.61%244K-84.85%1.95M-82.73%1.04M2,542.62%12.9M3,128.88%6.04M269.70%488K
Loan receivable (increase) decrease -------------------------------------99.51%42K
Decrease in deposits (increase) ------------206.11%34.75M--34.75M-109.91%-32.75M----199.16%330.35M508.69%287.22M-63,723.75%-333.16M
Sale of fixed assets ------------2.38%43K------42K--42K------------
Purchase of fixed assets -77.68%-12.63M84.78%-19.04M92.75%-7.11M15.83%-125.13M-60.15%-98.06M24.63%-148.67M34.07%-61.23M-73.68%-197.24M-417.12%-92.87M-128.11%-113.57M
Recovery of cash from investments -57.04%30.12M--15.39M--70.1M----------------------------
Cash on investment 45.45%-30M-------55M---15M------------------------
Other items in the investment business -----------------------------69.80%10M----1,203.63%33.11M
Net cash from investment operations -253.42%-12.3M96.66%-3.51M112.71%8.02M41.50%-104.96M-4.86%-63.07M-215.01%-179.42M-130.01%-60.15M137.76%156M327.68%200.39M-399.47%-413.09M
Net cash before financing -199.69%-76.48M133.30%53.89M65.57%-25.52M57.29%-161.84M56.02%-74.11M-4,421.26%-378.89M-246.16%-168.52M101.60%8.77M170.49%115.3M-280.21%-549.71M
Cash flow from financing activities
New borrowing 43.81%31.1M0.60%123.07M-72.04%21.62M--122.33M--77.33M----------------216.90%95.07M
Refund -2,122.44%-50.01M---2.25M-1.26%-2.25M-----480.16%-2.22M----99.42%-383K60.32%-63.09M43.51%-66.22M---158.99M
Issuing shares ------------------------------------151.72%1.03B
Interest paid - financing -36.90%-2.11M-78.47%-3.4M-142.07%-1.54M21.71%-1.9M50.77%-637K42.21%-2.43M54.31%-1.29M55.13%-4.21M47.91%-2.83M-265.47%-9.38M
Issuance expenses and redemption of securities expenses ----------------------------95.79%-1.28M95.46%-1.28M-1,342.31%-30.38M
Other items of the financing business -----767.06%-26M----64.50%-3M-----66.12%-8.45M-------5.09M--------
Net cash from financing operations -248.44%-22.81M-23.75%85.6M-78.95%15.37M731.36%112.26M1,727.57%73.01M77.91%-17.78M93.91%-4.49M-108.72%-80.48M-107.56%-73.66M259.30%922.76M
Effect of rate 102.90%8K-81.57%293K-61.40%-276K124.01%1.59M96.33%-171K79.41%-6.62M-135.90%-4.66M-284.05%-32.16M--12.98M820.07%17.48M
Net Cash -878.20%-99.29M381.34%139.48M-823.57%-10.15M87.50%-49.58M99.36%-1.1M-453.16%-396.67M-515.46%-173.01M-119.22%-71.71M-94.87%41.64M232.37%373.05M
Begining period cash 416.40%173.35M-58.84%33.57M-58.84%33.57M-83.18%81.56M-83.18%81.56M-17.64%484.85M-17.64%484.85M197.04%588.72M197.04%588.72M159.27%198.2M
Cash at the end 220.05%74.07M416.40%173.35M-71.18%23.14M-58.84%33.57M-73.86%80.29M-83.18%81.56M-52.25%307.18M-17.64%484.85M-36.26%643.35M197.04%588.72M
Cash balance analysis
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Deloitte Guan Huang Chen Fang Certified Public Accountants

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical Companies
Pharmaceutical Companies
Intraday-2.21%